Compositions and methods of use of antibodies targeting CD20 and CD3
TW202637597APending Publication Date: 2026-09-16CANDID THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114149511
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-10-17
- Filing Date
- 2025-12-16
- Publication Date
- 2026-09-16
Smart Images
Figure 00000000_0000_ABST
Abstract
Disclosed herein, in on aspect, is a method of treating an immune or inflammatory disease, comprising administering to a subject in need thereof a therapeutically effective amount of an antibody or antigen-binding fragment thereof that binds to CD20 and CD3, thereby treating the immune or inflammatory disease.
Need to check novelty before this filing date? Find Prior Art